Resident 360 Study Plans on AMBOSS

Find all Resident 360 study plans on AMBOSS

Fast Facts

A brief refresher with useful tables, figures, and research summaries

Seizures & Epilepsy

Seizures

Seizure is a common occurrence in hospitalized medical patients. Patients with preexisting epilepsy often have a lowered seizure threshold when hospitalized due to acute illness, medications used to treat the acute illness, and/or decreased antiepileptic drug (AED) levels. Decreased AED levels may result from poor compliance or interaction with new medications. Hospitalized patients may also present with new-onset seizure due to metabolic derangements, toxic ingestions, withdrawal from certain drugs (e.g., alcohol, benzodiazepines), infectious etiologies, or intracranial pathologies. Knowing how to manage both acute seizures in the hospital setting and status epilepticus is an important part of training. The American Academy of Neurology and American Epilepsy Society issued a guideline for workup and management of a first unprovoked seizure in adults. The following table summarizes common types of seizures.

Common Types of Seizures
[Image]

(Source: Initial Management of Seizure in Adults. N Engl J Med 2021.)

Workup for New Seizures

  • complete neurologic exam

  • laboratory analysis (including toxicology screen to look for metabolic, infectious, or toxic causes)

  • AED levels in patients with history of epilepsy

  • neuroimaging with noncontrast head CT (may also require MRI or electroencephalogram [EEG] monitoring)

  • lumbar puncture (LP) if presentation is suggestive of acute infectious process involving the central nervous system; should only be performed after a space-occupying brain lesion has been ruled out with neuroimaging

Differential Diagnosis

The following table summarizes the main differential diagnoses of a first generalized tonic-clonic seizure and provides information on the history taking, examination, and initial investigations.

Differential Diagnosis of Generalized Tonic-Clonic Seizures in Adults
[Image]

(Source: Initial Management of Seizure in Adults. N Engl J Med 2021.)

Management

The majority of seizures resolve spontaneously within 2 minutes without medication. However, establishing intravenous (IV) access in these patients is critical in case benzodiazepines (IV lorazepam or midazolam) are warranted due to prolonged seizure. If no IV access can be established, intramuscular (IM) midazolam or rectal diazepam can be used as alternatives. Read more on the efficacy of IV versus IM midazolam in the Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART).

Treatment is aimed at the underlying cause if found. Consider long-term AED treatment in patients for whom the underlying etiology is likely to persist or for prolonged or recurrent seizures. Abnormal findings on electroencephalography (EEG), abnormal neurologic status, and a second seizure all increase the probability of seizure recurrence. These three factors help clinicians stratify low, medium, and high risks and guide decisions about the initiation of antiseizure medication.

Probability of Another Seizure After a Single Seizure or Early Epilepsy and Recommendations for Use of Antiseizure Medications
[Image]

(Source: Initial Management of Seizure in Adults. N Engl J Med 2021.)

The following tables summarize first-line antiseizure medications and factors that affect the choice of antiepileptic drug.

First-Line Antiseizure Medications
[Image]

(Source: Initial Management of Seizure in Adults. N Engl J Med 2021.)

Factors Affecting Antiepileptic Drug Choice
[Image]

(Source: Initial Management of Epilepsy. N Engl J Med 2008.)

Status Epilepticus

Status epilepticus is a life-threatening emergency defined as one of the following:

  • ≥5 minutes of continuous seizures

  • ≥2 discrete seizures without complete recovery of consciousness in between

Management

  • Use the ABCD mnemonic: Airway management (often requires intubation), Breathing support with oxygen or mechanical ventilation, Circulation with IV access to administer key medications, Dextrose (make sure to check blood sugar)

  • Patients usually require transfer to an intensive care unit (ICU).

  • IV thiamine and dextrose should be considered as treatments for reversible causes of seizure.

  • Initial treatment with benzodiazepines: Administer IV lorazepam (or IM midazolam if there is difficulty obtaining IV access). IV access will still need to be established after IM treatment.

  • Follow initial treatment with a nonbenzodiazepine AED infusion to prevent recurrence. Most commonly used AEDs include fosphenytoin (preferred), phenytoin, valproate, and levetiracetam.

  • Treat refractory status epilepticus with one of the following: midazolam, propofol, or pentobarbital. All patients with refractory status epilepticus should have continuous EEG monitoring.

  • Preference for medications varies by institution because of a lack of clear guidelines.

  • Most patients with status epilepticus should be managed in an ICU setting.

Treatment Algorithm for Status Epilepticus
[Image]

(Source: Status Epilepticus in Adults. Lancet Neurol 2015.)

Research

Landmark clinical trials and other important studies

Research

Prenatal Carbamazepine Exposure and Academic Performance in Adolescents: A Population-Based Cohort Study

Ren T et al. Neurology 2022.

In a Danish population-based study, in utero exposure to carbamazepine was associated with lower ninth-grade language and mathematics examination scores.

Read the NEJM Journal Watch Summary

[Image]
Association of Enzyme-Inducing Antiseizure Drug Use with Long-term Cardiovascular Disease

Josephson CB et al. JAMA Neurol 2021.

In a large, population-based cohort of patients with epilepsy, those treated with enzyme-inducing antiseizure medications had an overall 21% higher risk for incident cardiovascular disease than those treated with other antiseizure medications.

Read the NEJM Journal Watch Summary

[Image]
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial

Marson A et al. Lancet 2021.

This phase 4 open-label randomized-controlled trial compared the long-term clinical effectiveness and cost-effectiveness of levetiracetam versus valproate in participants with newly diagnosed generalized or unclassifiable epilepsy. Levetiracetam was neither clinically effective nor cost-effective.

Read the NEJM Journal Watch Summary

[Image]
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

Kapur J et al. for NETT and PECARN Investigators. N Engl J Med 2019.

In the context of benzodiazepine-refractory convulsive status epilepticus, the anticonvulsant drugs levetiracetam, fosphenytoin, and valproate each led to seizure cessation and improved alertness by 60 minutes in approximately half the patients, and the three drugs were associated with similar incidences of adverse events.

View the NEJM Visual Abstract

[Image]

Reviews

The best overviews of the literature on this topic

Reviews

Initial Management of Seizure in Adults

Smith PEM. N Engl J Med 2021.

[Image]
Epilepsy in Older People

Sen A et al. Lancet 2020.

[Image]
Epilepsy in Adults

Thijs RD et al. Lancet 2019.

[Image]
[Image]
New-Onset Seizure in Adults and Adolescents: A Review

Gavvala JR and Schuele SU. JAMA 2016.

Approximately 8% to 10% of the population will experience a seizure during their lifetime. Only about 2% to 3% of patients go on to develop epilepsy.

[Image]
Epilepsy

Krishnamurthy KB. Ann Intern Med 2016.

[Image]

Guidelines

The current guidelines from the major specialty associations in the field

Guidelines

[Image]
[Image]